Steven Cohen (Point72) other Alnylam Pharmaceuticals, Inc.
Steven Cohen (Point72) other $81.2M of disclosed value in Alnylam Pharmaceuticals, Inc..
Signal
Investor Move
Action
Other
Capital
$81.2M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.